| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.011 | 0.9 |